ScanMed introduces device to help diagnose prostate cancer
OMAHA, Neb. — Omaha-based ScanMed has introduced the first non-invasive device for diagnosing prostate cancer.
The company is led by Randall Jones, a physician, who has developed the innovative PROCURETM MRI Coil to diagnose prostate cancer, which is one of the most common cancers in men in the United States.
With limited basic diagnosis and treatment procedures that are still deemed “controversial” by many in the medical world, Jones knew that he and his company had to take action and find a viable diagnostic alternative. All too often, men with elevated PSA will get a “blind” biopsy and are given a clean bill of health even though such biopsies are reported (in various peer reviewed scientific literature) to yield between 50 percent and 90 percent false negatives – meaning that the man did have cancer and it went undetected. After a cancer is left to grow for too long, then options are very few in terms of treatment – these are complete removal of the prostate (prostatectomy) or thermal ablation of the entire organ.
“The bottom line is that all we’ve had to work with up until now are invasive procedures that leave men incontinent, impotent, or both,” Jones said. “I’ve heard doctors compare obtaining non-image guided ‘blind’ biopsies to shooting arrows in the dark, which seems inexcusable in the realm of 21st century medicine. MRI is completely changing that paradigm. When I began to fully understand the implications and lack of options that patients have, I knew that I had to innovate a product that could greatly reduce the number of unwarranted invasive biopsies as well as provide a reliable and affordable means of early detection using MRI.”
Image courtesy of ScanMed
Source: PR Newswire